Don Rockey to Enzyme Inhibitors
This is a "connection" page, showing publications Don Rockey has written about Enzyme Inhibitors.
Connection Strength
0.151
-
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology. 2018 10; 155(4):1140-1153.
Score: 0.124
-
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model. J Hepatol. 2017 01; 66(1):75-85.
Score: 0.027